Low expression of VGLL4 positively correlated with poor prognosis of gastric tumor patients, and reduction in VGLL4 expression increased YAP-mediated TEAD activity and gastric tumor cell growth (36, 37). This evidence concerns the gene VGLL4 and gastric neoplasm.